Income Taxes (Tables)

12 Months Ended

Dec. 31, 2024

Income Tax Disclosure [Abstract]

Schedule of components of net loss from continuing operations before income taxes

The components of net income (loss) from continuing operations before income taxes are as follows:

	Year Ended December 31,
	2024		2023		2022
United States	$	191	$	92	$	(191)
Foreign	230		113		28
Net income (loss) from continuing operations before income tax expense	$	421	$	205	$	(163)

Schedule of components of the expense (benefit) for income taxes

The components of income tax expense (benefit) are as follows:

	Year Ended December 31,
	2024		2023		2022
Current
U.S. Federal	$	61	$	53	$	3
U.S. State	22		6		1
Foreign	84		50		38
Total	167		109		42
Deferred
U.S. Federal	(61)		(61)		3
U.S. State	(4)		(15)		1
Foreign	(17)		(8)		(33)
Total	(82)		(84)		(29)
Total income tax expense	$	85	$	25	$	13

Schedule of reconciliation of the U.S. federal statutory tax rate to the actual tax rate

The reconciliation of the U.S. federal statutory tax rate to the actual tax rate is as follows:

	Year Ended December 31,
	2024		2023		2022
Statutory U.S. federal income tax rate	21.0	%	21.0	%	21.0	%
State tax expense	2.2	%	1.8	%	(0.9)	%
Foreign earnings at rates different than U.S. federal rate	1.6	%	3.4	%	0.8	%
Foreign withholding taxes	0.9	%	3.1	%	(1.7)	%
Valuation allowance adjustments	1.5	%	3.4	%	6.3	%
Permanent items	(4.0)	%	(1.7)	%	0.7	%
Earnings from consolidated subsidiaries	—	%	—	%	(4.3)	%
Tax benefits from intraperiod tax allocation to discontinued operations	—	%	—	%	(29.8)	%
Tax credits	(2.5)	%	(4.7)	%	1.6	%
Impact of internal planning and restructuring	(3.0)	%	(6.4)	%	—	%
Impact of Divestitures	—	%	(6.9)	%	—	%
Other	2.6	%	(0.9)	%	(1.7)	%
Effective income tax rate	20.3	%	12.1	%	(8.0)	%

Schedule of deferred income taxes

	As of December 31,
	2024		2023
Deferred tax assets:
Reserves and other accrued expenses	$	90	$	65
Net operating loss carry forwards	82		82
Capitalized research and development expenditures	85		61
Interest limitation carry forwards	60		32
Stock compensation	33		33
Property and equipment	8		14
Differences in financial reporting and tax basis for:
Other	41		32
Less: Valuation allowance	(67)		(65)
Realizable deferred tax assets	332		254
Deferred tax liabilities:
Differences in financial reporting and tax basis for:
Identifiable intangible assets	(57)		(87)
Property and equipment	(35)		(25)
Other	(23)		(20)
Total deferred tax liabilities	(115)		(132)
Net deferred tax asset on balance sheet	$	217	$	122

Summary of net operating loss carryforward

At December 31, 2024, we had the following NOL, interest limitation, R&D credit, and state tax credit carry forwards:

	December 31, 2024
	Federal		State		Foreign
NOL carry forwards	$	—	$	521	$	238
Interest limitation carry forwards	159		105		80
R&D and state credit carry forwards	—		2		—

Summary of valuation allowance

At December 31, 2024 and 2023, we had the following valuation allowances:

	December 31,
	2024	2023
Federal	6	5
State	13	14
Foreign	48	46

Schedule of Unrecognized Tax Benefits Roll Forward

The Company had the following activity for unrecognized tax benefits:

	Year Ended December 31,
	2024		2023		2022
Balance at beginning of period	$	72	$	73	$	29
Tax positions related to current year additions	1		2		43
Additions for tax positions of prior years	4		1		1
Tax positions related to prior year reductions	—		(4)		—
Reductions due to lapse of statute of limitations on tax positions	(10)		—		—
Balance at end of period	$	67	$	72	$	73